<헤모위클리 9월 1주>

"달라진 공기, 9월아 반가워"

혈우전문지 헤모필리아라이프에서 보내드리는 주간 ‘헤모뉴스 스크랩’입니다. (수신 신청 : 010-3589-2694 / 현재 수신 804명)

■ 코헴과 헤모라이프, 혈우환우 정기 설문의 첫발 딛다
https://bit.ly/4gmUoLR

■ 혈우병 치료에서 꼭 알아야 할 개념 ‘트로프 레벨’
https://bit.ly/3TbOaEm

■ 주1회 혈우병 예방 응고인자 '알투비오', 식약처 신속심사 받는다
https://bit.ly/477Wwmn

■ "피하주사 바꾼 뒤 전성기 향해 가는 중"
https://bit.ly/3XaTV6t

■ 혈우병 치료제 엘록테이트 예방요법으로 통증이 줄어들고 삶의 질이 향상됐다
https://bit.ly/4dLC5xQ

■ '어쩔 수 없어' 라는 이름의 허들
https://bit.ly/4dKLNRj

■ 혈우재단, '9월 정형외과 클리닉 일정' 공지
http://www.hemophilia.co.kr/news/articleView.html?idxno=28116

■ 혈우병 환우들을 위한 감정 조절의 중요성과 방법 가이드
http://www.hemophilia.co.kr/news/articleView.html?idxno=28046

■ 캠프 참여 대만 환우들 "한국 혈우가족 대만 오면 꼭 연락 달라"
http://www.hemophilia.co.kr/news/articleView.html?idxno=28080

■ 화이자 유전자치료제 Durveqtix, 유럽서 사용 승인
http://www.hemophilia.co.kr/news/articleView.html?idxno=28037

■ 늘어난 B형 혈우병 반감기 연장 치료제, 선택 기준은?
https://www.docdocdoc.co.kr/news/articleView.html?idxno=3020477

■ 혈우병 환우들, 뼈 건강도 챙겨야
http://www.hemophilia.co.kr/news/articleView.html?idxno=28053

■ “농협왕진버스와 함께 농촌의 건강을 책임집니다”
http://www.hemophilia.co.kr/news/articleView.html?idxno=28120

■ 혈우병 A 환자의 치료비용, 나이가 많고 중증도 심할수록 높아
http://www.hemophilia.co.kr/news/articleView.html?idxno=28061

■ 더 많은 혈우병 기사를 보시려면 헤모라이프 신문페이지로 들어오세요.
헤모필리아라이프 http://www.hemophilia.co.kr